MONOPAR THERAPEUTICS INC reports a Return on Equity (ROE) of -11.07%.

What is MNPR's dividend yield?

MONOPAR THERAPEUTICS INC offers a dividend yield of 0.00%.

What is MNPR's Deepscope Quality Score?

Deepscope rates MNPR's overall financial quality at 38 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy MNPR?

Deepscope's AI Timing Score for MNPR is 70 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does MNPR belong to?

MONOPAR THERAPEUTICS INC is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.

Cổ phiếu MNPR (NASDAQ) | MONOPAR THERAPEUTICS INC

Stock Check Daily update data at 9:30 AM
(Price: 2026-06-11 | FS: 2026-03-31)

MNPR

MONOPAR THERAPEUTICS INC

US:NASDAQ STOCK Healthcare >> Biotechnology News 91

USD 59.10

-0.33 (-0.55%) Day Change

Watchlist Portfolio Compare Chart

0.02

D/E

-11.1%

ROE

-10.9%

ROA

0.00%

Div Yield

MONOPAR THERAPEUTICS INC
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 59.10 Price -0.33 (-0.55%) Day Change	NEWS SCORE: 91

MNPR Chất lượng tổng thể của cố phiếu Không tốt ( Chất lượng = 38) nhưng Thời điểm mua ...(Sign In to See)...

Loading chart...

38 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: Tỷ lệ ROE tương đối thấp
Tỷ lệ ROA tương đối thấp
[-] Tốc độ tăng trưởng ROE dưới mức tiêu chí của chúng tôi.
Lịch sử ROE tương đối thấp
ROA quá thấp so với ROE
Tốc độ tăng trưởng ROA dưới mức tiêu chí của chúng tôi.
Biên lợi nhuận ròng tương đối thấp.
Tốc độ tăng trưởng biên lợi nhuận ròng dưới mức tiêu chí của chúng tôi

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Lorem ipsum dolor sit amet

Unlock timing signals and detailed reasons

Chi tiết hơn, sẽ thấy rằng các yếu tố chất lượng Không tốt , Sức khỏe tài chính Không tốt lắm , và khả năng kiếm lợi nhuận Không tốt , ...

Yếu tố Chất lượng

39%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	91
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	59.10
PBV / Sector	2.94 / 4.79
Earning Per Share	-2.22

PE / Sector	N/A / 18.05
PEG or PE/Growth / Sector	N/A / 0.62
Average 1M Daily Value	10.19 M GREAT
Average 1W Daily Value	7.16 M

Yếu tố Kỹ thuật

28%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Sức khỏe tài chính

50%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Khả năng kiếm lợi nhuận

37%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	N/A / 468.85
NPM Average (%) / Sector	N/A / -1,531.69
NPM Change Average (%) / Sector	N/A / 5,028.65
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-10.86 / 31.69
ROA Average (%) / Sector	-48.04 / -353.18
ROA Change Average (%) / Sector	-21.03 / 5,214.65
ROE (%) / Sector	-11.07 / 10.58
ROE Average (%) / Sector	-60.74 / 27.64
ROE Change Average (%) / Sector	-22.56 / 2,048.88
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Lợi tức cho nhà đầu tư

Dividend (%) / Sector	N/A / 0.05
Dividend Average (%) / Sector	N/A / 16.49
Dividend Change Average (%) / Sector	N/A / 4.77

Chi tiết đăng ký

Analyze Date	2026-06-12 09:43:12
Symbol	MNPR
Name	MONOPAR THERAPEUTICS INC
Sector	Healthcare >> Biotechnology
Market	NASDAQ
Listed Shares	6.70 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	398.06 / 9,010.81

Tin tức, Dự báo ước tính

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 1000 Skokie Boulevard, Wilmette, IL, United States, 60091

Phone: 847 388 0349

Website: https://www.monopartx.com

Sector: Healthcare >> Biotechnology

Description: Monopar Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics for the treatment of cancer in the United States. The company develops ALXN1840, a late-stage, investigational once-daily and oral medicine; MNPR-101, a proprietary humanized monoclonal antibody that is conjugated with different radioisotopes for the treatment of advanced solid tumors expressing urokinase plasminogen activator receptor; and MNPR-101-Zr, which is in phase 1 imaging and dosimetry clinical trial, a radiopharmaceutical imaging agent comprised of MNPR-101 conjugated to zirconium-89. It develops MNPR-101-Lu, a Phase1a stage radiotherapeutic comprised of MNPR-101 conjugated to actinium-225. The company has collaborations NorthStar to develop radio-immuno-therapeutics targeting severe COVID-19; Excel Diagnostics and Nuclear Oncology Center, for the investigational imaging agent MNPR-101-Zr and investigational therapeutic agent MNPR-101-Lu; license agreement with Alexion to develop and commercialize ALXN1840, a drug candidate for Wilson disease. The company was founded in 2014 and is headquartered in Wilmette, Illinois.